Tg Therapeutics (TGTX) Capital Expenditures (2012 - 2026)
Tg Therapeutics' (TGTX) quarterly Capital Expenditures came in at $51000.0 in Q1 2026, up 104.0% year-on-year from $25000.0 in Q1 2025, and down 23.88% quarter-over-quarter from $67000.0 in Q4 2025.
Tg Therapeutics (TGTX) Capital Expenditures (2012 - 2026) Analysis & Trends
Tg Therapeutics' Capital Expenditures history runs 14 years deep, the most recent figure standing at $51000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 104.0% year-over-year to $51000.0 in Q1 2026; TTM through Mar 2026 was $240000.0, a 242.86% increase from a year earlier, with the FY2025 full-year figure at $214000.0, up 375.56% from the prior year.
- Capital Expenditures retreated to $51000.0 in Q1 2026 per TGTX's latest filing, from $67000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $80000.0 in Q3 2025 and bottomed at $3000.0 in Q4 2022.
- The 4-year median for Capital Expenditures is $24500.0 (2024), against an average of $32400.0.
- Across the five-year window, Capital Expenditures sank 96.25% in 2022 and surged 233.33% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at $3000.0 in 2022, then soared by 600.0% to $21000.0 in 2024, then surged by 219.05% to $67000.0 in 2025, then decreased by 23.88% to $51000.0 in 2026.
- Per Business Quant, the three latest TGTX Capital Expenditures figures stand at $51000.0 (Q1 2026), $67000.0 (Q4 2025), and $80000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Tg Therapeutics | 8.88 Bn | 8.80 Bn | 171.41 Mn | 51,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,000.00 |
| Mar 31, 2026 | 51,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Dec 31, 2025 | 67,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Sep 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Mar 31, 2022 | 7,000.00 |